https://graniterecord.org/bill/2026/sb465.html classifying xylazine as a schedule III controlled drug. en-us Fri, 04 Sep 2026 00:00:00 +0000 https://graniterecord.org/bill/2026/sb465.htmlSB465:2026-04-23:inexpedient-to-legislate-ma-vv-04-23-202Thu, 23 Apr 2026 00:00:00 +0000classifying xylazine as a schedule III controlled drug. Inexpedient to Legislate: MA VV 04/23/2026 Status: House: INEXPEDIENT TO LEGISLATE · Senate: PASSED/ADOPTED WITH AMENDMENT https://graniterecord.org/bill/2026/sb465.htmlSB465:2026-04-15:majority-committee-report-inexpedient-toWed, 15 Apr 2026 00:00:00 +0000classifying xylazine as a schedule III controlled drug. Majority Committee Report: Inexpedient to Legislate 04/14/2026 (Vote 11-5; RC) Status: House: INEXPEDIENT TO LEGISLATE · Senate: PASSED/ADOPTED WITH AMENDMENT https://graniterecord.org/bill/2026/sb465.htmlSB465:2026-04-15:minority-committee-report-ought-to-passWed, 15 Apr 2026 00:00:00 +0000classifying xylazine as a schedule III controlled drug. Minority Committee Report: Ought to Pass Status: House: INEXPEDIENT TO LEGISLATE · Senate: PASSED/ADOPTED WITH AMENDMENT https://graniterecord.org/bill/2026/sb465.htmlSB465:2026-04-14:executive-session-04-14-2026-01-00-pm-gpTue, 14 Apr 2026 00:00:00 +0000classifying xylazine as a schedule III controlled drug. Executive Session: 04/14/2026 01:00 pm GP 153 Status: House: INEXPEDIENT TO LEGISLATE · Senate: PASSED/ADOPTED WITH AMENDMENT https://graniterecord.org/bill/2026/sb465.htmlSB465:2026-04-07:full-committee-work-session-04-07-2026-0Tue, 07 Apr 2026 00:00:00 +0000classifying xylazine as a schedule III controlled drug. Full Committee Work Session: 04/07/2026 01:00 pm GP 153 Status: House: INEXPEDIENT TO LEGISLATE · Senate: PASSED/ADOPTED WITH AMENDMENT https://graniterecord.org/bill/2026/sb465.htmlSB465:2026-03-31:public-hearing-03-31-2026-01-30-pm-gp-15Tue, 31 Mar 2026 00:00:00 +0000classifying xylazine as a schedule III controlled drug. Public Hearing: 03/31/2026 01:30 pm GP 153 Status: House: INEXPEDIENT TO LEGISLATE · Senate: PASSED/ADOPTED WITH AMENDMENT https://graniterecord.org/bill/2026/sb465.htmlSB465:2026-03-12:introduced-in-recess-of-03-12-2026-and-rThu, 12 Mar 2026 00:00:00 +0000classifying xylazine as a schedule III controlled drug. Introduced (in recess of) 03/12/2026 and referred to Environment and Agriculture Status: House: INEXPEDIENT TO LEGISLATE · Senate: PASSED/ADOPTED WITH AMENDMENT https://graniterecord.org/bill/2026/sb465.htmlSB465:2026-03-05:committee-amendment-2026-0842s-aa-vv-03-Thu, 05 Mar 2026 00:00:00 +0000classifying xylazine as a schedule III controlled drug. Committee Amendment # 2026-0842s, AA, VV; 03/05/2026 Status: House: INEXPEDIENT TO LEGISLATE · Senate: PASSED/ADOPTED WITH AMENDMENT https://graniterecord.org/bill/2026/sb465.htmlSB465:2026-03-05:ought-to-pass-with-amendment-2026-0842s-Thu, 05 Mar 2026 00:00:00 +0000classifying xylazine as a schedule III controlled drug. Ought to Pass with Amendment #2026-0842s, MA, VV; OT3rdg; 03/05/2026 Status: House: INEXPEDIENT TO LEGISLATE · Senate: PASSED/ADOPTED WITH AMENDMENT https://graniterecord.org/bill/2026/sb465.htmlSB465:2026-02-20:committee-report-ought-to-pass-with-amenFri, 20 Feb 2026 00:00:00 +0000classifying xylazine as a schedule III controlled drug. Committee Report: Ought to Pass with Amendment # 2026-0842s, 03/05/2026; Vote 5-0; CC Status: House: INEXPEDIENT TO LEGISLATE · Senate: PASSED/ADOPTED WITH AMENDMENT https://graniterecord.org/bill/2026/sb465.htmlSB465:2026-02-05:hearing-02-10-2026-room-100-sh-01-30-pm-Thu, 05 Feb 2026 00:00:00 +0000classifying xylazine as a schedule III controlled drug. Hearing: 02/10/2026, Room 100, SH, 01:30 pm; SC 5A Status: House: INEXPEDIENT TO LEGISLATE · Senate: PASSED/ADOPTED WITH AMENDMENT https://graniterecord.org/bill/2026/sb465.htmlSB465:2026-01-07:introduced-01-07-2026-and-referred-to-juWed, 07 Jan 2026 00:00:00 +0000classifying xylazine as a schedule III controlled drug. Introduced 01/07/2026 and Referred to Judiciary Status: House: INEXPEDIENT TO LEGISLATE · Senate: PASSED/ADOPTED WITH AMENDMENT